Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Andrulis
Molecular Signaling in Multiple Myeloma: Association of RAS/RAF Mutations and MEK/ERK Pathway Activation
Oncogenesis
Cancer Research
Molecular Biology
Related publications
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells
PLoS ONE
Multidisciplinary
Prohibitins Role in Cellular Survival Through Ras-Raf-Mek-Erk Pathway
Journal of Cellular Physiology
Clinical Biochemistry
Cell Biology
Physiology
Targeting the Ras/Raf/Mek/Erk Pathway in Hepatocellular Carcinoma (Review)
Oncology Letters
Cancer Research
Oncology
Modulation of the Akt/Ras/Raf/Mek/Erk Pathway by A3 Adenosine Receptor
Purinergic Signalling
Molecular Neuroscience
Cell Biology
Molecular Biology
Cellular
MicroRNA‑98 Suppresses Cell Growth and Invasion of Retinoblastoma via Targeting the IGF1R/k‑Ras/Raf/MEK/ERK Signaling Pathway
International Journal of Oncology
Cancer Research
Oncology
MicroRNA‑143‑3p Suppresses Cell Growth and Invasion in Laryngeal Squamous Cell Carcinoma via Targeting the K‑Ras/Raf/Mek/Erk Signaling Pathway
International Journal of Oncology
Cancer Research
Oncology
The Intermediate-Activity L597VBRAF Mutant Acts as an Epistatic Modifier of Oncogenic RAS by Enhancing Signaling Through the RAF/MEK/ERK Pathway
Genes and Development
Genetics
Developmental Biology
Oxymatrine Inhibits Proliferation and Migration of Vulvar Squamous Cell Carcinoma Cells via Attenuation of the RAS/RAF/MEK/ERK Pathway
Cancer Management and Research
Oncology
Epigallocatechin-3-Gallate Inhibits the Growth and Increases the Apoptosis of Human Thyroid Carcinoma Cells Through Suppression of EGFR/RAS/RAF/MEK/ERK Signaling Pathway
Cancer Cell International
Cancer Research
Oncology
Genetics
